CTRI/2021/01/030860尚未招募未知
CLINICAL EVALUATION OF TREATMENT TOXICITY OF ARBUDA WITH SPECIAL REFERENCE TO PRAKRITI,KOSTHA,AGNI AND SATMYA
DEPARTMENT OF VIKRITI VIGYA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients above 18 years
- •Patients with ECOG <2
- •Patients receiving chemotherapy for solid tumors
排除标准
- •Pregnant and lactating women.
- •Not willing to complete the consent process as describe in proforma.
- •Inability to comply with study procedures and methods.
研究者
相似试验
招募中
不适用
Pathological analysis of side effecte to the treatment of adult T-cell leukemiaAdult T-cell leukemiaJPRN-UMIN000017469Division of Emerging Infectious Diseases, Graduate School of MedicineTohoku University5
已完成
不适用
Study of the therapy using ketamine in refractory depressiorefractory depressive disorderdepression, anxiety, anhedoneaD003865JPRN-jRCTs051210192Murai Toshiya10
尚未招募
2 期
clinical and microbiological efficacy of arimedadi oilCTRI/2021/05/033384mme kulsum
招募中
1 期
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma.Liver NeoplasmsCarcinoma, HepatocellularDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialHepatocellular carcinomaRPCEC00000022Center of Molecular Immunology (CIM)15
招募中
1 期
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment.Primary malignant colon and breast lesion and metastatic liver lesions.Liver NeoplasmsDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesRPCEC00000023Center of Molecular Immunology (CIM)15